2016 China Border Trade and Development Summit

According to the international authoritative medical advisory body IMS statistics, nearly 5 years, the international pharmaceutical market in order to 14%-17% the rate of sustained growth. 2015, China's pharmaceutical import and export market for the first time exceeded 100 billion U.S. dollars mark, accounting for 54.97% of total exports.
At the same time, with the rapid development of China's pharmaceutical R & D and production technology, domestic raw materials and finished products are gradually being favored by overseas markets, especially in developing countries. Therefore, the international market channels, optimize the process of international trade become the two core problems of the domestic pharmaceutical companies to competition will consider mining.
2016 China cross-border trade development summit and the India pharmaceutical market seminar forum, from the commercial development of China Health Industry Association (CHBD) jointly organized with global cross-border trading platform was medical technology, will be held October 2016 24-25 in a passenger of Shenzhen held a grand kylin villa.
Share the experience and the collision point of view conference invited outstanding pharmaceutical enterprises between China and India, vertical industry leader and pioneer of Internet financial investment elite, looking for a new direction for the development of cross-border trade Chinese medicine, new idea of win-win cooperation to provide international perspective for the industry.

Discussion of the summit will be discussed from the following aspects:
One, the basic laws of overseas market development and cooperation model
The seminar will focus on the success of outstanding domestic enterprises medicine trade industry case study of domestic pharmaceutical companies to expand international business, landing, to overcome the difficulties of cross-border transactions is inevitable. The guest speaker of Chinese medicine wiqida pharmaceutical, biological, biological Maigao Poucan chairman and general manager of the company, through the above in terms of raw materials and products of biological vaccine exports achieved remarkable results in the enterprise actual combat experience, show the success of international pharmaceutical trade.
Two, registered regulatory requirements and market channel characteristics of developing countries
As the world's second largest population and pharmaceutical research leader in the country, the potential of the huge market in India. India famous pharmaceutical company Wockhardt (India local vaccine leader enterprise) vice president, Mr. Sharma Rajesh, will attend the summit and to share the market situation and trade risk in India drug industry, especially in the field of raw materials. At the same time, Mr. Tarun Gupta, general manager of India LUPIN JOINT FORCE, former president of the Asia Pacific region, the company will also serve as one of the speaker participants, will bring the detailed information on the countries of South Asia drug registration regulations and procedures for the guests.
Three, platform resource integration and cross-border development
Traditional companies want to return to the main track of the times, from the Internet and industrial finance is essential to help. How efficient and low cost to promote the brand and channel, the upgrading of the industrial use of the Internet platform, cross-border trade of pharmaceutical companies is at stake. At the same time, the traditional enterprises should use the Internet platform to provide financial services and credit support to optimize cross-border business, business model innovation.
It is reported that the titer of technology co-founder and senior engineer, before Tencent background system easy fast / Jingdong CPS system manager, nonferrous metals co founder, general manager of Qianhai financial benefits, the first investment co-founder, and Tobey network market analysts have been affected by cross-border cooperation, and invited speaker pharmaceutical trade Internet venture investment.
The summit will be officially opened in October 24, 2016, a half day. The site is located in Shenzhen Nanshan District City, the beautiful scenery of the kylin villa, participants are expected to more than 100 pharmaceutical companies, logistics, translation, foreign trade registered and three party service providers more than 10, the Internet platform and financial industry investors nearly 20, and the medical industry and local well-known media. Poly potential outside the pharmaceutical trade development, the participating companies can also get an open and free platform, according to their business needs is expected to reach a mutually beneficial and win-win cooperation relationship.